These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31782875)

  • 1. Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post-transplant cytoxan for sickle cell disease.
    Patel DA; Dhedin N; Chen H; Karnik L; Gatwood K; Culos K; Mohan S; Engelhardt BG; Kitko C; Connelly J; Satyanarayana G; Jagasia M; De La Fuente J; Kassim A
    Transpl Infect Dis; 2020 Feb; 22(1):e13222. PubMed ID: 31782875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative.
    de la Fuente J; Dhedin N; Koyama T; Bernaudin F; Kuentz M; Karnik L; Socié G; Culos KA; Brodsky RA; DeBaun MR; Kassim AA
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1197-1209. PubMed ID: 30500440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide/Bendamustine in Pediatric and Young Adult Patients with Hematologic Malignancies.
    Katsanis E; Sapp LN; Varner N; Koza S; Stea B; Zeng Y
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):2034-2039. PubMed ID: 29908231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease.
    Kassim AA; de la Fuente J; Nur E; Wilkerson KL; Alahmari AD; Seber A; Bonfim C; Simões BP; Alzahrani M; Eckrich MJ; Horn B; Hanna R; Dhedin N; Rangarajan HG; Gouveia RV; Almohareb F; Aljurf M; Essa M; Alahmari B; Gatwood K; Connelly JA; Dovern E; Rodeghier M; DeBaun MR
    Blood; 2024 Jun; 143(25):2654-2665. PubMed ID: 38493482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease.
    Bhat DK; Olkhanud PB; Gangaplara A; Seifuddin F; Pirooznia M; Biancotto A; Fantoni G; Pittman C; Francis B; Dagur PK; Saxena A; McCoy JP; Pfeiffer RM; Fitzhugh CD
    Front Immunol; 2021; 12():757279. PubMed ID: 34917079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts.
    Ebens CL; McGrath JA; Tamai K; Hovnanian A; Wagner JE; Riddle MJ; Keene DR; DeFor TE; Tryon R; Chen M; Woodley DT; Hook K; Tolar J
    Br J Dermatol; 2019 Dec; 181(6):1238-1246. PubMed ID: 30843184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
    Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
    Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease.
    Chu Y; Talano JA; Baxter-Lowe LA; Verbsky JW; Morris E; Mahanti H; Ayello J; Keever-Taylor C; Johnson B; Weinberg RS; Shi Q; Moore TB; Fabricatore S; Grossman B; van de Ven C; Shenoy S; Cairo MS
    Front Immunol; 2022; 13():1055497. PubMed ID: 36569951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Intensity Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric Inherited Immune Deficiencies and Bone Marrow Failure Syndromes.
    Klein OR; Bapty S; Lederman HM; Younger MEM; Zambidis ET; Jones RJ; Cooke KR; Symons HJ
    J Clin Immunol; 2021 Feb; 41(2):414-426. PubMed ID: 33159275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective observational study of immune reconstitution following transplantation with post-transplant reduced-dose cyclophosphamide from HLA-haploidentical donors.
    Nakamae H; Fujii K; Nanno S; Okamura H; Nakane T; Koh H; Nakashima Y; Nakamae M; Hirose A; Teshima T; Hino M
    Transpl Int; 2019 Dec; 32(12):1322-1332. PubMed ID: 31432532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis.
    Yu X; Liu L; Xie Z; Dong C; Zhao L; Zhang J; Gu J; Zhu HH
    Crit Rev Oncol Hematol; 2019 Jan; 133():120-128. PubMed ID: 30661648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial.
    Bolaños-Meade J; Cooke KR; Gamper CJ; Ali SA; Ambinder RF; Borrello IM; Fuchs EJ; Gladstone DE; Gocke CB; Huff CA; Luznik L; Swinnen LJ; Symons HJ; Terezakis SA; Wagner-Johnston N; Jones RJ; Brodsky RA
    Lancet Haematol; 2019 Apr; 6(4):e183-e193. PubMed ID: 30878319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral hemodynamic changes after haploidentical hematopoietic stem cell transplant in adults with sickle cell disease.
    Aumann MA; Richerson W; Song AK; Davis LT; Pruthi S; Davis S; Patel NJ; Custer C; Kassim AA; DeBaun MR; Donahue MJ; Jordan LC
    Blood Adv; 2024 Feb; 8(3):608-619. PubMed ID: 37883803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reconstitution after T-cell replete HLA-haploidentical transplantation.
    McCurdy SR; Luznik L
    Semin Hematol; 2019 Jul; 56(3):221-226. PubMed ID: 31202434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide.
    Kurita N; Sakamoto T; Kato T; Kusakabe M; Yokoyama Y; Nishikii H; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    Ann Hematol; 2021 May; 100(5):1295-1301. PubMed ID: 33580280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA Haploidentical Stem Cell Transplant with Pretransplant Immunosuppression for Patients with Sickle Cell Disease.
    Pawlowska AB; Cheng JC; Karras NA; Sun W; Wang LD; Bell AD; Gutierrez L; Rosenthal J
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):185-189. PubMed ID: 28939451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases.
    Brodsky RA; Luznik L; Bolaños-Meade J; Leffell MS; Jones RJ; Fuchs EJ
    Bone Marrow Transplant; 2008 Oct; 42(8):523-7. PubMed ID: 18622413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia.
    Nagler A; Labopin M; Dholaria B; Angelucci E; Afanasyev B; Cornelissen JJ; Sica S; Meijer E; Ciceri F; Van Gorkom G; Kröger N; Martin H; Pioltelli P; Risitano A; Canaani J; Savani BN; Sanz J; Mohty M
    Clin Cancer Res; 2021 Feb; 27(3):843-851. PubMed ID: 33148668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
    Eapen M; Brazauskas R; Walters MC; Bernaudin F; Bo-Subait K; Fitzhugh CD; Hankins JS; Kanter J; Meerpohl JJ; Bolaños-Meade J; Panepinto JA; Rondelli D; Shenoy S; Williamson J; Woolford TL; Gluckman E; Wagner JE; Tisdale JF
    Lancet Haematol; 2019 Nov; 6(11):e585-e596. PubMed ID: 31495699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.